New Long-Acting shot offers hope for kids with Hard-to-Treat HIV

NCT ID NCT06749054

Recruiting now Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

Summary

This study is testing a long-acting HIV medicine called lenacapavir in children and teenagers who have been treated before and whose current medicines are not fully working. Researchers want to see if the drug is safe, how it behaves in the body, and if it helps control the virus when given as an injection or a pill alongside other HIV medicines. The study will also ask the young participants how easy the medicine is to take.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Be Part Research Pty (Ltd)
RECRUITING

Paarl, 7626, South Africa
CRISMO Research Centre
RECRUITING

Germiston, 1401, South Africa
Clinical Research Institute of South Africa (CRISA)
RECRUITING

KwaDukuza, 4449, South Africa
Durban International Clinical Research Site, Enhancing Care Foundation
RECRUITING

KwaZulu - Natal, 4093, South Africa
FAMCRU
RECRUITING

Cape Town, 7505, South Africa
Grady Health System, Ponce De Leon Center
RECRUITING

Atlanta, Georgia, 30308, United States
Perinatal HIV Research Unit (PHRU)
RECRUITING

Soweto, 2013, South Africa
Rahima Moosa Mother and Child Hospital
RECRUITING

Johannesburg, 2112, South Africa
Wits RHI Shandukani Research Centre CRS
RECRUITING

Johannesburg, 2038, South Africa

Conditions

Explore the condition pages connected to this study.

HIV-1-INFECTION